Smolle, E.; Fink-Neuboeck, N.; Lindenmann, J.; Smolle-Juettner, F.; Pichler, M.
The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer. Cancers 2019, 11, 1118.
https://doi.org/10.3390/cancers11081118
AMA Style
Smolle E, Fink-Neuboeck N, Lindenmann J, Smolle-Juettner F, Pichler M.
The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer. Cancers. 2019; 11(8):1118.
https://doi.org/10.3390/cancers11081118
Chicago/Turabian Style
Smolle, Elisabeth, Nicole Fink-Neuboeck, Joerg Lindenmann, Freyja Smolle-Juettner, and Martin Pichler.
2019. "The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer" Cancers 11, no. 8: 1118.
https://doi.org/10.3390/cancers11081118
APA Style
Smolle, E., Fink-Neuboeck, N., Lindenmann, J., Smolle-Juettner, F., & Pichler, M.
(2019). The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer. Cancers, 11(8), 1118.
https://doi.org/10.3390/cancers11081118